Jiaxi WU

Person

Elmsford, NY, US

People

Patents Grantslast 30 patents

Information Patent Grant
IL2 and peptide-MHC complex fusion proteins and methods of use thereof
- Patent number 12,091,440
- Issue date Sep 17, 2024
- REGENERON PHARMACEUTICALS, INC.
- Jiaxi Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
IL-2 variants with reduced binding to IL-2 receptor alpha and uses...
- Patent number 11,834,485
- Issue date Dec 5, 2023
- REGENERON PHARMACEUTICALS, INC.
- Jiaxi Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
IL2 agonists and methods of use thereof
- Patent number 11,725,034
- Issue date Aug 15, 2023
- REGENERON PHARMACEUTICALS, INC.
- Jiaxi Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
INTERFERON RECEPTOR ANTAGONISTS AND USES THEREOF
- Publication number 20240376229
- Publication date Nov 14, 2024
- Regeneron Pharmaceuticals, Inc.
- Vidur GARG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL12 RECEPTOR AGONISTS AND METHODS OF USE THEREOF
- Publication number 20240270836
- Publication date Aug 15, 2024
- Regeneron Pharmaceuticals, Inc.
- Aaron CHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING CANCER WITH A COMBINATION OF ADOPTIVE CELL THER...
- Publication number 20240148867
- Publication date May 9, 2024
- Regeneron Pharmaceuticals, Inc.
- David DiLillo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERFERON RECEPTOR AGONISTS AND USES THEREOF
- Publication number 20240101633
- Publication date Mar 28, 2024
- Regeneron Pharmaceuticals, Inc.
- Eva-Maria WEICK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IL-2 VARIANTS WITH REDUCED BINDING TO IL-2 RECEPTOR ALPHA AND USES...
- Publication number 20240067690
- Publication date Feb 29, 2024
- Regeneron Pharmaceuticals, Inc.
- Jiaxi Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INTERFERON RECEPTOR AGONISTS AND USES THEREOF
- Publication number 20240067691
- Publication date Feb 29, 2024
- Regeneron Pharmaceuticals, Inc.
- Eva-Maria WEICK
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INTERLEUKIN-2 PROPROTEINS AND USES THEREOF
- Publication number 20230391844
- Publication date Dec 7, 2023
- Regeneron Pharmaceuticals, Inc.
- Jiaxi WU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERLEUKIN-2 PROPROTEINS AND USES THEREOF
- Publication number 20230382969
- Publication date Nov 30, 2023
- Regeneron Pharmaceuticals, Inc.
- Supriya PATEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL2 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20230331800
- Publication date Oct 19, 2023
- Regeneron Pharmaceuticals, Inc.
- Jiaxi WU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL IL2 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20230312665
- Publication date Oct 5, 2023
- Regeneron Pharmaceuticals, Inc.
- Jiaxi WU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IL27 RECEPTOR AGONISTS AND METHODS OF USE THEREOF
- Publication number 20230110958
- Publication date Apr 13, 2023
- Regeneron Pharmaceuticals, Inc.
- Arielle Glatman Zaretsky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL IL2 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20230053563
- Publication date Feb 23, 2023
- Regeneron Pharmaceuticals, Inc.
- Jiaxi WU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL12 RECEPTOR AGONISTS AND METHODS OF USE THEREOF
- Publication number 20230051304
- Publication date Feb 16, 2023
- Regeneron Pharmaceuticals, Inc.
- Aaron CHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL2-BASED THERAPEUTICS AND METHODS OF USE THEREOF
- Publication number 20220402989
- Publication date Dec 22, 2022
- Regeneron Pharmaceuticals, Inc.
- Jiaxi Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL IL2 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20220362395
- Publication date Nov 17, 2022
- Regeneron Pharmaceuticals, Inc.
- Jiaxi WU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL IL2 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20220220182
- Publication date Jul 14, 2022
- Regeneron Pharmaceuticals, Inc.
- Jiaxi WU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IL-2 VARIANTS WITH REDUCED BINDING TO IL-2 RECEPTOR ALPHA AND USES...
- Publication number 20210324030
- Publication date Oct 21, 2021
- Regeneron Pharmaceuticals, Inc.
- Jiaxi Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL IL2 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20210188934
- Publication date Jun 24, 2021
- Regeneron Pharmaceuticals, Inc.
- Jiaxi WU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL IL2 AGONISTS AND METHODS OF USE THEREOF
- Publication number 20210187027
- Publication date Jun 24, 2021
- Regeneron Pharmaceuticals, Inc.
- Jiaxi WU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

IL2 and peptide-MHC complex fusion proteins and methods of use thereof

IL-2 variants with reduced binding to IL-2 receptor alpha and uses...

IL2 agonists and methods of use thereof

Patents Applicationslast 30 patents

INTERFERON RECEPTOR ANTAGONISTS AND USES THEREOF

IL12 RECEPTOR AGONISTS AND METHODS OF USE THEREOF

METHODS OF TREATING CANCER WITH A COMBINATION OF ADOPTIVE CELL THER...

INTERFERON RECEPTOR AGONISTS AND USES THEREOF

IL-2 VARIANTS WITH REDUCED BINDING TO IL-2 RECEPTOR ALPHA AND USES...

INTERFERON RECEPTOR AGONISTS AND USES THEREOF

INTERLEUKIN-2 PROPROTEINS AND USES THEREOF

INTERLEUKIN-2 PROPROTEINS AND USES THEREOF

IL2 AGONISTS AND METHODS OF USE THEREOF

NOVEL IL2 AGONISTS AND METHODS OF USE THEREOF

IL27 RECEPTOR AGONISTS AND METHODS OF USE THEREOF

NOVEL IL2 AGONISTS AND METHODS OF USE THEREOF

IL12 RECEPTOR AGONISTS AND METHODS OF USE THEREOF

IL2-BASED THERAPEUTICS AND METHODS OF USE THEREOF

NOVEL IL2 AGONISTS AND METHODS OF USE THEREOF

NOVEL IL2 AGONISTS AND METHODS OF USE THEREOF

IL-2 VARIANTS WITH REDUCED BINDING TO IL-2 RECEPTOR ALPHA AND USES...

NOVEL IL2 AGONISTS AND METHODS OF USE THEREOF

NOVEL IL2 AGONISTS AND METHODS OF USE THEREOF